Jeff Aronin is chairman and CEO of Paragon Biosciences, which, along with partners, has invested approximately $1 billion in portfolio companies since 2017 and expects ongoing investments of up to $500 million annually.
Chief Executive’s June survey of 278 U.S. CEOs shows leading confidence indicator now at 5.5/10, the lowest reading in nearly a decade. Majority forecasts worsening conditions in the year ahead, though not a recession.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.